AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹1,928 Cr | ₹2,648 Cr | ₹5,335 Cr | ₹2,845 Cr | ₹2,365 Cr |
What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹1,928 Cr |
Mar2023 | ₹2,648 Cr |
Mar2022 | ₹5,335 Cr |
Mar2021 | ₹2,845 Cr |
Mar2020 | ₹2,365 Cr |
How is Consolidated Net Profit of AUROBINDO PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,928 Cr | -27.21 | |
Mar2023 | ₹2,648 Cr | -50.36 | |
Mar2022 | ₹5,335 Cr | 87.51 | |
Mar2021 | ₹2,845 Cr | 20.32 | |
Mar2020 | ₹2,365 Cr | - |
Compare Consolidated Net Profit of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹71,403.6 Cr | -2.2% | 6.3% | 9.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,126.0 Cr | 1.4% | 4.1% | 18.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,568.0 Cr | -2.1% | 4.2% | 59.1% | Stock Analytics | |
CIPLA | ₹125,156.0 Cr | -0.1% | 5% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,176.0 Cr | -0.3% | 3% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,716.1 Cr | -1.5% | 1.7% | -5.4% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -2.2% |
6.3% |
9.6% |
SENSEX | 0.2% |
2.9% |
8.7% |
You may also like the below Video Courses